
| Chemical & Physical Properties | |
|---|---|
| CAS Number | 1431368-48-7 |
| Catalog No. | 2A-2189585 |
| Chinese Name | rel-N-[(1R,2S)-2-苯基环丙基]-4-哌啶胺 |
| Synonyms | N-[(1R,2S)-2-Phenylcyclopropyl]-4-piperidinamine; GSK-LSD1 2HCL; GSK-LSD1 (hydrochloride) |
| Molecular Formula | C14H20N2 |
| Molecular Weight | 289.24 |
| Density | 1.1±0.1 g/cm3 |
| Boiling Point | 347.4±42.0 °C at 760 mmHg |
| Appearance | white to beige |
| Water Solubility | H2O: soluble20mg/mL, clear |
| Storage Condition | 2-8°C |
| Application | GSK-LSD1 is an LSD1 inhibitor. GSK-LSD1 reduces food intake and body weight and improves insulin sensitivity and glycemic control in obese mouse models. GSK-LSD1 also improves NAFLD. GSK-LSD1 inhibits |
| PubChem ID | 329825454 |
| SMILES | c1ccc(C2CC2NC2CCNCC2)cc1 |
| InChI | InChI=1S/C14H20N2/c1-2-4-11(5-3-1)13-10-14(13)16-12-6-8-15-9-7-12/h1-5,12-16H,6-10H2/t13-,14+/m0/s1 |
| InChI Key | BASFYRLYJAZPPL-UHFFFAOYSA-N |
| NACRES Code | NA.77 |
| UNSPSC | 51111800 |
| Transport Info | Product name: GSK LSD1 dihydrochloride |
| Related Products in Specialty Chemicals | ||
|---|---|---|
| CHOLINE IODIDE | 17773-10-3 | 2A-2189574 |
| quinuclidin-4-ylMethanaMine | 67496-78-0 | 2A-2189576 |
| 3-(1,1-difluoroethyl)aniline | 40788-05-4 | 2A-2189582 |
| 4-Chloro-2-methoxybenzyl alcohol | 90296-27-8 | 2A-2189583 |
| 4-CHLORO-2-METHOXYBENZYL ALCOHOL | 55685-75-1 | 2A-2189584 |
| 1-Bromo-2-fluoro-4,5-dimethylbenzene | 5100-97-0 | 2A-2189587 |
| 2-broMo-4,5-diMethylbenzenaMine | 22364-29-0 | 2A-2189588 |
| 2H-Benzimidazol-2-one,1,3-dihydro-1-(1-propenyl)-,(E)-(9CI) | 95926-75-3 | 2A-2189590 |
| Cyclopropanecarbonitrile, 2-phenyl-, trans- | 5590-14-7 | 2A-2189591 |
| (2R)-1-Amino-3-(1,2,3,4-tetrahydroisoquinolin-2-yl)propan-2-ol | 1616077-53-2 | 2A-2189593 |
| Browse all Specialty Chemicals products » | ||
Phone:
630-322-8886
630-322-8887
Email:
Office Locations:
Chicago, IL, USA
San Francisco, CA, USA